Dibenzyline (Concordia Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Dibenzyline drug offered from Concordia Pharmaceuticals Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Concordia Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Phenoxybenzamine Hydrochloride |
| SUBSTANCE NAME: | PHENOXYBENZAMINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1953-01-26 |
| END MARKETING DATE: | 0000-00-00 |
Dibenzyline HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dibenzyline from Concordia Pharmaceuticals Inc. |
| LABELER NAME: | Concordia Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 1953-01-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59212-001_2fa06156-4f46-468e-b1cd-4cfc16d2e7bb |
| PRODUCT NDC: | 59212-001 |
| APPLICATION NUMBER: | NDA008708 |
Other PHENOXYBENZAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
